Albert Seymour

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bedford, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Paul Alloway, Attorney-in-Fact for Albert Seymour
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Albert Seymour

Form 4 holding President and Chief Executive Officer, Director

Homology Medicines, Inc.

Security class
Common Stock
Shares / value
150,874
Estimated value
$85,395
Report date
06 Sep 2023
Price
$0.5660
Ownership
Direct
Form 4 holding President and Chief Executive Officer, Director

Homology Medicines, Inc.

Security class
Restricted Stock Units
Shares / value
9,380
Estimated value
$10,789
Report date
06 Sep 2023
Price
$1.15
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Albert Seymour

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .